review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1013479295 |
P356 | DOI | 10.2165/00003495-198224050-00004 |
P698 | PubMed publication ID | 6129123 |
P2093 | author name string | G. M. Shenfield | |
P2860 | cites work | The reported increase in mortality from asthma: a clinico-functional analysis | Q72055916 |
Management of acute asthma in childhood. A randomized evaluation of beta-adrenergic agents | Q72134998 | ||
Treatment of chronic asthma in children with a sustained-release preparation of theophylline in addition to beta 2-stimulating agents | Q72439576 | ||
Has the change to beta-agonists combined with oral theophylline increased cases of fatal asthma? | Q72471574 | ||
Has the change to beta-agonists combined with oral theophylline increased cases of fatal asthma? | Q72477146 | ||
Oral theophylline and fatal asthma | Q72482867 | ||
Outpatient bronchodilator therapy | Q74459945 | ||
Mechanism of bronchoconstriction during inhalation of dust | Q76420624 | ||
Atropine methonitrate and isoprenaline in bronchial asthma | Q76463414 | ||
SOME ADRENERGIC DRUGS AND ATROPINE METHONITRATE GIVEN BY INHALATION FOR ASTHMA: A COMPARATIVE STUDY | Q76692209 | ||
The response to bronchodilators in intrinsic asthma | Q78891416 | ||
Adenosine 3',5'-phosphate in biological materials. I. Purification and properties of cyclic 3',5'-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine 3',5'-phosphate in human urine | Q79360576 | ||
Slow release salbutamol and Tedral in the treatment of reversible airways obstruction | Q95780992 | ||
VARIATION OF DRUG ACTION ON AIRWAY OBSTRUCTION IN MAN | Q33601796 | ||
Use of Ephedrine in Bronchodilator Therapy | Q34014619 | ||
Role of Autonomic Nervous System and the Cough Reflex in the Increased Responsiveness of Airways in Patients with Obstructive Airway Disease* | Q34088549 | ||
Alterations in cyclic adenosine monophosphate metabolism in human bronchial asthma. I. Leukocyte responsiveness to -adrenergic agents | Q34497318 | ||
Assessment of combined oral theophylline and inhaled beta-adrenoceptor agonist bronchodilator therapy | Q34516188 | ||
Comparative efficacy of salbutamol by pressurized aerosol and wet nebulizer in acute asthma | Q34519176 | ||
Differentiation of Receptor Systems activated by Sympathomimetic Amines | Q34706728 | ||
The importance of calcium ions for the regulation of guanosine 3':5'-cyclic monophosphage levels | Q34754435 | ||
Ipratropium bromide in acute asthma. | Q34777702 | ||
Combined treatment with sustained-release theophylline and beta2-adrenoceptor-stimulating agents in chronic childhood asthma | Q34778404 | ||
A study of the adrenotropic receptors | Q34854653 | ||
Efficacy of orally administered salbutamol and theophylline in pre-schoolchildren with asthma | Q35114046 | ||
Interaction of corticosteroids and catecholamines in the treatment of asthma | Q36435482 | ||
Interaction between isoprenaline and aminophylline in asthma | Q36445462 | ||
Bronchodilatation and the site of airway resistance in severe chronic bronchitis | Q36454799 | ||
A comparison of responses to bronchodilator drugs in chronic bronchitis and chronic asthma | Q36475361 | ||
Relative contributions of large and small airways to flow limitation in normal subjects before and after atropine and isoproterenol | Q37043920 | ||
Comparison of aerosol ipratropium bromide and salbutamol in chronic bronchitis and asthma | Q66892713 | ||
Terbutaline and terbutaline combined with theophylline in asthmatics | Q66969757 | ||
Committee on the Review of Medicines. Recommendations on barbiturate preparations | Q67019728 | ||
Theophylline and aerosolized terbutaline in the treatment of bronchial asthma. Double-blind comparison of optimal doses | Q67255262 | ||
The treatment of asthma | Q67256275 | ||
Theophylline disposition in obesity | Q67289523 | ||
A re-evaluation of ephedrine/theophylline combinations in the treatment of asthma | Q67328610 | ||
Asthma deaths in Cardiff 1963-74: 90 deaths outside hospital | Q67461396 | ||
An evaluation of theophylline/ephedrine with and without hydroxyzine in asthma | Q67516809 | ||
Bronchodilating effect and side effects of beta2- adrenoceptor stimulants by different modes of administration (tablets, metered aerosol, and combinations thereof). A study with salbutamol in asthmatics | Q67707589 | ||
Inhaled and oral salbutamol in exercise-induced asthma | Q67824661 | ||
Inhaled atropine sulfate: dose response characteristics | Q67824666 | ||
[Can the association of an atropinic (SCH 1000) and a sympathicomimetic improve the bronchodilatation obtained by a sympathicomimetic alone (author's transl)] | Q68546174 | ||
Metabolic actions in human bronchial muscle associated with ACTH induced relaxation | Q68646335 | ||
Cyclic nucleotide levels in incubations of guinea pig trachea | Q68686670 | ||
Adverse Effects of Phenobarbital on Corticosteroid Metabolism in Patients with Bronchial Asthma | Q69168940 | ||
Bronchodilators. Part I | Q70058389 | ||
Histamine release in vitro: inhibition by catecholamines and methylxanthines | Q70091316 | ||
A controlled trial of the use of single versus combined-drug therapy in the treatment of acute episodes of asthma | Q70151490 | ||
Value of combining B2 sympathomimetic metered aerosol and oral theophylline in children with asthma | Q70162177 | ||
Effectiveness of terbutaline and theophylline alone and in combination in exercise-induced bronchospasm | Q70162820 | ||
Nebulised ipratropium bromide and salbutamol in chronic bronchitis | Q70538822 | ||
Assessment and management of severe asthma | Q70626645 | ||
The Effects of Oral Doses of Theophylline and Fenoterol on Exercise-Induced Asthma | Q70758665 | ||
Plasma theophylline assay service for outpatients | Q70778044 | ||
Asthma mortality in Birmingham 1975-7: 53 deaths | Q71155270 | ||
Bronchodilator effects of low doses of oral theophylline and terbutaline in asthmatic subjects | Q71323937 | ||
A comparative trial of slow-release aminophylline, salbutamol and a half dose combination in the prevention of childhood asthma | Q71397973 | ||
The role of the theophyllines in asthma therapy | Q39183574 | ||
Controlled Assessment of Oral Bronchodilators for Asthmatic Children | Q39208473 | ||
Drugs in the treatment of asthma | Q39229764 | ||
Bronchodilator drugs | Q39285600 | ||
An evaluation of pharmacotherapy for exercise-induced asthma | Q39288186 | ||
Comparison of cromoglycate (cromolyn) and theophylline in controlling symptoms of chronic asthma. A collaborative study | Q39423576 | ||
Exercise-induced asthma. Pharmacological assessment of single drugs and drug combinations | Q39587870 | ||
Comparison of Aerosolized Atropine, Isoproterenol Atropine plus Isoproterenol, Disodium Cromoglycate and Placebo in the Prevention of Exercise-Induced Asthma | Q39613004 | ||
A simple standardized approach to childhood asthma | Q39709627 | ||
Role of tobacco smoking in pharmacokinetics | Q39723934 | ||
Clinical Pharmacokinetics of Theophylline | Q39758588 | ||
Monitoring Serum Theophylline Levels | Q39758602 | ||
The pharmacology and toxicology of a new tropane alkaloid derivative | Q39782140 | ||
A comparison of the bronchodilator activity of Sch 1000 and salbutamol | Q39799657 | ||
Ipratropium bromide, salbutamol and prednisolone in bronchial asthma and chronic bronchitis | Q39863183 | ||
Bronchodilator therapy (second of two parts). | Q39865264 | ||
Combined inhalation of salbutamol and ipratropin in chronic bronchial obstruction | Q39908116 | ||
Combined Cholinergic Antagonist and β2-Adrenoceptor Agonist Bronchodilator Therapy by Inhalation | Q39908422 | ||
The use of corticosteroids in the treatment of acute asthma | Q39954399 | ||
Autonomic control of airway smooth muscle and airway secretions | Q40076805 | ||
In-vitro and in-vivo effects of theophylline and beta 2-adrenostimulants in combination | Q40083320 | ||
Potentiation of isoprenaline-induced plasma cyclic AMP response by aminophylline in normal and asthmatic subjects | Q40196043 | ||
Fixed combination drug therapy | Q40336215 | ||
Ephedrine therapy in asthmatic children. Clinical tolerance and absence of side effects | Q40746371 | ||
Bronchodilator Effects of Terbutaline and Aminophylline Alone and in Combination in Asthmatic Patients | Q40850767 | ||
Bronchodilator Effects of Metaproterenol and Oxtriphylline in Asthma | Q40920734 | ||
The value of atropine in the documentation of reversible airways obstruction | Q41029439 | ||
Additive interaction of aminophylline and salbutamol in asthma: an in vivo study using dose-response curves | Q41033663 | ||
A comparative study of atropine methonitrate, salbutamol, and their combination in airways obstruction | Q41041806 | ||
Long-term study on a new beta2-sympathicomimetic agent and a combination of an oral theophylline-ethylenediamine with retard effect and hexoprenaline (author's transl) | Q41045223 | ||
Emergency treatment of asthma. A comparison of two treatment regimens | Q41051728 | ||
Clinical assessment of bronchodilator drugs delivered by aerosol | Q41191545 | ||
Comparison of inhaled atropine sulphate and atropine methonitrate | Q41200057 | ||
Comparison of aerosolized atropine, isoproterenol, atropine plus isoproterenol, disodium cromoglycate and placebo in the prevention of exercise-induced asthma | Q41335895 | ||
Theophylline-salbutamol interaction: bronchodilator response to salbutamol at maximally effective plasma theophylline concentrations | Q41821496 | ||
The effect of different nebulizers with and without intermittent positive pressure breathing on the absorption and metabolism of salbutamol | Q41884026 | ||
Pharmacokinetics of inhaled substances | Q42153419 | ||
Pressurized sympathomimetic aerosols and their lack of relationship to asthma mortality in Australia | Q43661837 | ||
Nonadrenergic inhibitory nervous system in human airways | Q43957845 | ||
Theophylline disposition in patients with hepatic cirrhosis | Q44113747 | ||
A comparison of orciprenaline and salbutamol administered orally in 12 adult asthmatic patients | Q44287792 | ||
Successful treatment of persistent extreme dyspnea "status asthmaticus". Use of theophylline ethylene diamine (aminophylline, U. S. P.) intravenously. 1938. | Q49095484 | ||
Investigation into use of drugs preceding death from asthma | Q49214673 | ||
Regulation by beta-adrenergic receptor and muscarinic cholinergic receptor activation of intracellular cyclic AMP and cyclic GMP levels in rat lung slices. | Q53727717 | ||
Combined vs. single-entity pharmacologic inhibition of induced asthma. | Q54551783 | ||
Evaluation of oral bronchodilator therapy in asthmatic children. Bronchodilators in asthmatic children. | Q54559649 | ||
The fate of nebulized salbutamol (albuterol) administered by intermittent positive pressure respiration to asthmatic patients | Q54647624 | ||
Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline. | Q54659082 | ||
Factors influencing pulmonary resistance | Q54677517 | ||
Effects of Salbutamol and Isoprenaline Phenylephrine in Reversible Airways Obstruction | Q55004832 | ||
Theophylline in asthma | Q66697406 | ||
Asthma deaths in Cardiff 1963-74: 53 deaths in hospital | Q66845086 | ||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 414-439 | |
P577 | publication date | 1982-11-01 | |
P1433 | published in | Drugs | Q3040094 |
P1476 | title | Combination bronchodilator therapy | |
Combination Bronchodilator Therapy | |||
P478 | volume | 24 |
Q39461647 | Asthma: 2. Trends in pharmacologic therapy |
Q41142164 | Bronchodilator treatment for partially reversible chronic obstructive airways disease |
Q36300505 | Distribution Analysis via Mass Spectrometry Imaging of Ephedrine in the Lungs of Rats Orally Administered the Japanese Kampo Medicine Maoto |
Q43628545 | Interactive effects of systemically administered salbutamol and aminophylline in patients with chronic obstructive pulmonary disease |
Q34674974 | Salbutamol in the 1980s. A reappraisal of its clinical efficacy |
Q37401706 | Stability-Indicating RP-HPLC Method for the Simultaneous Estimation of Doxofylline and Terbutalinesulphate in Pharmaceutical Formulations |
Q40895597 | Theophylline. Current thoughts on the risks and benefits of its use in asthma |
Search more.